| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $47.2M | — | -10.2% |
| Cost of Revenue | $9.8M | — | -8.3% |
| Gross Profit | $37.4M | — | -10.7% |
| R&D Expense | $4.6M | — | -16.9% |
| SG&A Expense | $16.2M | — | +2.4% |
| Operating Income | -$17.2M | — | -10.2% |
| Interest Expense | $1.6M | +16.3% | +19.8% |
| Net Income | -$18.0M | -91.2% | -12.8% |
| EPS (Basic) | -$0.28 | — | -12.0% |
| EPS (Diluted) | -$0.28 | — | -12.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $9.5M | -10.9% | -28.6% |
| Short-term Investments | $42.3M | +12.4% | -32.5% |
| Accounts Receivable | $30.4M | -28.0% | -2.4% |
| Inventory | $36.4M | +0.9% | -4.1% |
| Current Assets | $123.5M | -6.5% | -17.4% |
| Total Assets | $184.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $7.2M | — | +72.5% |
| Capital Expenditures | $3.1M | — | -13.6% |
| Investing Cash Flow | -$7.8M | — | -312.7% |
| Financing Cash Flow | -$588K | — | -108.5% |
| Free Cash Flow | $4.2M | — | +537.9% |
| -10.6% |
| Current Liabilities | $34.5M | +12.6% | +4.0% |
| Long-term Debt | $55.8M | +0.4% | +4.6% |
| Total Liabilities | $106.9M | +3.5% | +6.4% |
| Stockholders' Equity | $77.2M | -11.6% | -26.7% |